This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Robert A. Beardsley: Innovator in Antitumor Therapy
Introduction
Robert A. Beardsley is an accomplished inventor based in the United States. He has made significant contributions to the field of cancer treatment, particularly through his innovative approaches to antitumor therapy. His work focuses on enhancing the effectiveness of existing cancer treatments.
Latest Patents
Robert A. Beardsley holds a patent for a method titled "Combination Antitumor Therapy." This patent outlines methods for treating cancers that respond to antimetabolite or antimitotic anti-cancer agents. The methods involve using at least one anti-cancer agent selected from antimetabolite anti-cancer agents, antimitotic anti-cancer agents, and combinations thereof, along with a superoxide dismutase mimetic to enhance the therapeutic effects of the anti-cancer agents.
Career Highlights
Beardsley is currently associated with Kereos, Inc., where he continues to develop innovative cancer therapies. His work has been instrumental in advancing treatment options for patients suffering from various types of cancer. Despite having no patents listed under his name, his contributions to the field are noteworthy.
Collaborations
Robert A. Beardsley has collaborated with Jeffery L. Keene, among others, to further research and development in cancer therapies. Their combined expertise has led to advancements in the understanding and treatment of cancer.
Conclusion
Robert A. Beardsley is a notable figure in the field of cancer treatment, particularly for his work on combination antitumor therapies. His innovative approaches have the potential to significantly impact cancer treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile